Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

6.09
Delayed Data
As of Feb 24
 -0.20 / -3.18%
Today’s Change
5.80
Today|||52-Week Range
50.70
-37.55%
Year-to-Date
How to Dig Deep for Value in These Exuberant Markets
Feb 23 / TheStreet.com - Paid Partner Content
Value Investors Have to Go Deeper
Feb 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close6.29
Today’s open6.16
Day’s range5.80 - 6.45
Volume64,489
Average volume (3 months)51,511
Market cap$4.9M
Dividend yield9.35%
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+50.96%
Earnings growth (this year)+54.50%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)+536.36%
P/E ratio0.2
Price/Sales7.92
Price/Book0.15

Competitors

 Today’s
change
Today’s
% change
--VANC Pharmaceuticals...+0.01+3.70%
SSKNSTRATA Skin Sciences...-0.02-3.67%
OPXAOpexa Therapeutics I...-0.07-6.52%
BSPMBiostar Pharmaceutic...-0.07-2.45%
Data as of 3:59pm ET, 02/24/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$5.63
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.8M
Net profit margin-843.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer &
Head-Investor Relations
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs